Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Benjamin Holmgren"'
Publikováno v:
Leukemia & Lymphoma. 62:1958-1966
AML with mutated NPM1 occurs in all age groups. Yet, the mutational pattern is not extensively studied in the very old, which may hamper appropriate risk assessment. Herein we examined 22 cases of NPM1-mutated de novo AML in patients older than 75, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f789a1cf3e4288c6dd83feaa6c3f48d
https://doi.org/10.1080/10428194.2021.1894650
https://doi.org/10.1080/10428194.2021.1894650
Autor:
Maria Planck, Lena Tran, Despoina Violidaki, Mohammed S. I. Mansour, Tomas Seidal, Benjamin Holmgren, Annika Dejmek, Kim Hejny, Katalin Dobra, Kajsa Ericson Lindquist, Rikard Mohlin, Hans Brunnström, Ulrich Mager
Publikováno v:
Acta Cytol
Introduction: Programmed death-ligand 1 (PD-L1) expression is used for treatment prediction in non-small cell lung cancer (NSCLC). While cytology may be the only available material in the routine clinical setting, testing in clinical trials has mainl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b730b752be77e0e94f5157abf0cc3c6
https://doi.org/10.1159/000517078
https://doi.org/10.1159/000517078
Autor:
Brunnström, Mohammed S. I. Mansour, Karina Malmros, Ulrich Mager, Kajsa Ericson Lindquist, Kim Hejny, Benjamin Holmgren, Tomas Seidal, Annika Dejmek, Katalin Dobra, Maria Planck, Hans
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 9; Pages: 4517
Immune checkpoint inhibitors (ICI) targeting programmed cell death-1 or its ligand (PD-L1) have improved outcomes in non-small cell lung cancer (NSCLC). High tumor PD-L1 expression, detected by immunohistochemistry (IHC) typically on formalin-fixed p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::10e243b1fc6ffe9ebb39d154d29df4d8
Autor:
Mohammed S I, Mansour, Karina, Malmros, Ulrich, Mager, Kajsa, Ericson Lindquist, Kim, Hejny, Benjamin, Holmgren, Tomas, Seidal, Annika, Dejmek, Katalin, Dobra, Maria, Planck, Hans, Brunnström
Publikováno v:
International journal of molecular sciences. 23(9)
Immune checkpoint inhibitors (ICI) targeting programmed cell death-1 or its ligand (PD-L1) have improved outcomes in non-small cell lung cancer (NSCLC). High tumor PD-L1 expression, detected by immunohistochemistry (IHC) typically on formalin-fixed p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fd7848056da6fac306e38a60f7923df6
https://pubmed.ncbi.nlm.nih.gov/35562908
https://pubmed.ncbi.nlm.nih.gov/35562908
Autor:
Louise, Pettersson, Benjamin, Holmgren, Gunnar, Juliusson, Vladimir Lj, Lazarevic, Mats, Ehinger
Publikováno v:
Leukemialymphoma. 62(8)
AML with mutated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fc0b02c0134a45a5752fba41c8c4c125
https://pubmed.ncbi.nlm.nih.gov/33711909
https://pubmed.ncbi.nlm.nih.gov/33711909